UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates
Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Google+
THOR on Instagram
THOR on YouTubeCategory Archives: THE FUTURE OF LLLT
THOR LLLT presentation at United Nations – Global Health Impact Forum
This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).
Low Level Laser (LLLT) “regenerates teeth”
TV, radio and newspapers all over the world got very excited last week reporting that “laser regenerates teeth” following a Harvard study. The study showed that LLLT stimulates the stem cells resident in the tooth pulp to form dentin (for details click below). This is the highest profile announcement for any LLLT paper ever and will add significant awareness and credibility for everyone in the field. Congratulations and huge thanks to the author Dr Praveen Arany B.D.S., M.D.S., M.M.Sc., Ph.D. who is now a Clinical Investigator at NIH.
TV report about the LED TBI trial soon to commence at Harvard
TV report about the LED treatment for TBI. Trial soon to commence at Spaulding Hospital (Harvard Medical School) Boston MA
Read full article on wcvb.com
THOR at Harvard MIT
David Sengeh has been developing powered limbs at MIT for amputees (like the bionic man). Where the powered limb attaches to the body (the stump of the original leg) it gets very sore. David has been using our standard THOR products to heal the stump and reduce pain. It works very well, though it takes a lot of time to treat the whole area. I am in Boston now to help David start clinical trials with a new device we designed that will treat the whole stump. The amputee puts the the leg stump into the LED treatment cylinder and gets a complete treatment in just one minute :-)
Continue reading Mike Hamblin Harvard LLLT TBI video interview
LLLT for Traumatic Brain Injury (TBI) by Prof. Michael Hamblin, Wellman Centre for Photomedicine, Harvard Medical School.
LLLT LED patch for Alzheimer’s
Clarimedix Inc., will present results of animal studies on its LLLT LED patch for Alzheimer’s disease at the International Conference of the Alzheimer’s & Parkinson’s Disease Conference in Barcelona on March 9.
The next decade of LLLT – the barriers to mainstream adoption
Because LLLT modulates cellular oxidation and energy production it could potentially affect a wide range of diseases, injuries or other dysfunctions in the body.
By the end of the next decade, it is possible LLLT may be used in almost every department of every hospital (and every medicine cabinet of every home).
Given the amount of good quality research published over the last decade, why isn’t it part of mainstream medicine already?